Pharma Stocks
-
Barclays Raises its Price Target on Jazz Pharmaceuticals (JAZZ) to $225
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is one of the 10 Best Fast Growth Stocks to Invest In Now. On April 19,…
Read More » -
Q4 Earnings Roundup: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Segment
Let’s dig into the relative performance of Merck (NYSE:MRK) and its peers as we unravel the now-completed Q4 branded pharmaceuticals…
Read More » -
Rajesh Palviya of Axis Sec suggests Glenmark Pharma, Marico, SAIL shares to buy on 24 April
Stock market today: The domestic benchmark indices, Nifty 50 and Sensex edged lower on Friday, 24 April extending losses for…
Read More » -
Trade Alert: CEO, MD & Executive Director Of Clarity Pharmaceuticals Michelle Parker Has Sold Stock
We wouldn’t blame Clarity Pharmaceuticals Ltd (ASX:CU6) shareholders if they were a little worried about the fact that Michelle Parker,…
Read More » -
Pharma leads gains as healthcare sector rebounds
Paul MacDonald, president & co-chief investment officer at Harvest ETFs, joins BNN Bloomberg to discuss the outlook on the markets.…
Read More » -
Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here
Xenon Pharmaceuticals Inc (NASDAQ:XENE) is among the best 52-week high US stocks to buy. On April 19, Xenon Pharmaceuticals Inc…
Read More » -
Piramal Pharma Ltd Sees Sharp Open Interest Surge Amid Bu…
Open Interest and Volume Dynamics The latest data reveals that Piramal Pharma’s open interest (OI) in derivatives rose sharply by…
Read More » -
Will New Epidiolex and Xywav Data Shift Jazz Pharmaceuticals’ (JAZZ) Neuroscience Value Narrative?
Jazz Pharmaceuticals has already presented six new clinical data abstracts on Epidiolex and Xywav at the 2026 American Academy of…
Read More » -
Should You Forget Pfizer and Buy This Pharma Stock Instead?
Pfizer(NYSE: PFE) and AbbVie(NYSE: ABBV) are two pharmaceutical giants that seem to be headed in opposite directions. Pfizer’s stock is…
Read More » -
Is It Too Late To Consider Royalty Pharma (RPRX) After Strong 57% One Year Rally?
If you are wondering whether Royalty Pharma’s current share price still makes sense after a strong run, the key is…
Read More »
